Print This Page
Share this page: More
 

AB Portable Driver System in the Outpatient Environment

This trial is no longer in process.

Summary of Trial: 

The purpose of this study is to collect clinical data on the use of the AB5000 Portable Driver System.  AB5000 is approved for use in patients suffering from reversible ventricular dysfunction.  However its use is limited to the hospital environment.  The Portable Driver System may potentially allow patients supported with AB5000 to be discharge out of the hospital.  

Principal Investigators:Drs. John Conte and Ashish Shah
Study Coordinators:

Dzifa Dordunoo, MSN, RN
Email: edordun1@jhmi.edu
(410) 955-3597

Tamara Bubb, BS
Email:  tbubb1@jhmi.edu
(410) 502-5438

Study Long Title: 

A multi-center, prospective, single arm clinical trial designed to evaluate the safety and performance of the AB Portable Driver System in the outpatient environment (VOYAGER)

Study Short Title: N/A
JHU eIRB Number:NA_0002242
Funding Source:ABIOMED, Inc.
Inclusions: 

The patient is currently on an AB5000 Circulatory Support System (in accordance FDA-approved indications for use) who is suffering acute cardiac dysfunction and is potentially recoverable.

  • The patient is male or female, age 18 years or older
  • The patient is able to ambulate unassisted
  • The patient is on stable oral anticoagulation over 7 days (INR: 2-4) with no active bleeding
  • The patient is willing and able to read, understand and sign the study specific informed consent form
  • Agrees to comply with study protocol requirements, including all follow-up visits and completion of

Exclusions: 

  • The patient, pre-device implant, is qualified as a transplant candidate
  • There is an absence of a trained companion
  • There is an absence of psychosocial support
  • The patient has an inadequate home environment, such as poor access which may hinder movements
  • The patient has experienced hypotension in last 24 hours based on two consecutive readings spaced by 8 hours with systolic blood pressures < 90 mmHg
  • The patient requires respiratory assistance
  • The patient has an active infection (positive blood culture and/or Body T > 38°C, and/or WBC > 12K/µL)
  • The patient requires tube feeding
  • The patient has any other medical condition requiring hospitalization
Clinical Trial Site:  

Johns Hopkins Hospital
600 North Wolfe Street, Blalock 618
Baltimore, MD 21287-4618

This is a multi-center study.

Start Date:2009
Anticipated End Date: N/A
Compensation for Participating:  None












































 

 

HVI Employees: Manage Clinical Trials

Do you need to add, update or delete a clinical trial for the Heart and Vascular Institute website? Use this form.

Ranked #1 by US News & World Report

US News and World Report Best HospitalsJohns Hopkins Hospital has earned the top spot in US News News & World Report's annual rankings of American hospitals — for the 21st year in a row.

This year, the Heart and Vascular Institute ranked #3 nationally for the Heart & Heart Surgery program.

Make a Gift to the Heart and Vascular Institute

Out-of-State and International Patients - Find Out More

Trainings and Fellowships

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System, All rights reserved.

Privacy Policy and Disclaimer